In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
ABSTRACT: Objectives: Gram-negative pathogens causing respiratory infection in people with cystic fibrosis and bronchiectasis are becoming progressively more resistant to conventional antibiotics. Although cefiderocol is licenced for the treatment of infections due to Gram-negative organisms, there...
Main Authors: | Michael M Tunney, J Stuart Elborn, Chloe S McLaughlin, Christopher M Longshaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716524000298 |
Similar Items
-
Letter in response to first case of persistent Stenotrophomonas maltophilia bacteremia due to septic thrombosis successfully treated with a Cefiderocol-containing regimen
by: Gayatree Nayak, et al.
Published: (2024-03-01) -
Iron metabolism in bacterial cells: from physiological significance to a new class of antimicrobial agents
by: Kozlov A.V., et al.
Published: (2022-06-01) -
Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis
by: Kevin J. Psoter, et al.
Published: (2017-07-01) -
On Burkholderiales order microorganisms and cystic fibrosis in Russia
by: Olga L. Voronina, et al.
Published: (2018-02-01) -
Organisms isolated from adults with Cystic Fibrosis
by: Moore John E, et al.
Published: (2004-12-01)